Zealand Pharma

Developer of protein therapies for the treatment of diabetes and gastrointestinal diseases

placeGlostrup, Capital Region Of Denmark, Denmark calendar_todayFounded 1998 groups235 employees language zealandpharma.com

Social engagement

Social engagement: 53.2K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

11 investors on record; 4 have since exited.

Investor typeCountShare
Venture capital327%
Private equity764%
Other / undisclosed19%

Recent activity

16 Jun 2026
Recognition
regulatory
12 Jun 2026
Event
American Diabetes Association Scientific Sessions 2026
4 Jun 2026
Event
2026 Scientific Sessions of the American Diabetes Association (ADA)
Coming soon